Related Experiment Video
Updated: Aug 23, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Fusarium fungaemia in immunocompromised patients
T G Jensen1, B Gahrn-Hansen, M Arendrup
1Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark. t.g.jensen@ouh.fyns-amt.dk
Abstract:
Fusarium spp. cause infections only rarely in immunologically competent hosts, but disseminated infection may occur in severely immunocompromised patients. Symptoms of disseminated infection are persistent fever, despite broad-spectrum antibacterial and antifungal treatment, associated with skin lesions, most commonly on the extremities, in 60-80% of patients. A mortality rate of 50-75% has been reported for patients with disseminated fusariosis. Despite treatment failures, amphotericin B remains the preferred drug, in part because of lack of alternatives. Voriconazole is a promising new agent, but more clinical experience is required.
Insights
Fusarium fungal infections rarely affect healthy individuals but can cause severe, disseminated disease in immunocompromised patients. High mortality rates underscore the need for effective treatments beyond amphotericin B.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Fusarium species are ubiquitous fungi.
- Infections are rare in immunocompetent hosts.
- Disseminated fusariosis occurs in severely immunocompromised individuals.
Observation:
- Persistent fever despite broad-spectrum antimicrobial therapy is a key symptom.
- Skin lesions, typically on extremities, are present in 60-80% of cases.
- Disseminated fusariosis carries a high mortality rate of 50-75%.
Findings:
- Amphotericin B is the current standard treatment despite frequent failures.
- Lack of effective alternative therapies contributes to its continued use.
- Voriconazole shows promise but requires further clinical validation.
Implications:
- Improved diagnostic and therapeutic strategies for disseminated fusariosis are crucial.
- Further research into novel antifungal agents is warranted.
- Enhanced clinical vigilance for Fusarium infections in immunocompromised populations is necessary.
Related Concept Videos
Cryptococcal Meningitis
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Candidiasis
Rocky Mountain Spotted Fever
